Inhibrx Biosciences, Inc. (INBX) Competitors

$12.86

$0.32 (2.55%)
Last update: 04:00 PM EST
Day's range
$12.25
Day's range
$12.93

Inhibrx Biosciences, Inc. Competitors

Symbol Share Price Market Cap P/E Ratio Employee Count
MACK

Merrimack Pharmaceuticals, Inc.

$15.15 $223.97 M -168.28 0
CELC

Celcuity Inc.

$10.44 $394.95 M -3.42 87
KRON

Kronos Bio, Inc.

$0.69 $42.07 M -0.64 8
LYEL

Lyell Immunopharma, Inc.

$0.42 $124.01 M -0.34 300
IKNA

Ikena Oncology, Inc.

$1.14 $55.50 M -1.32 10
MLYS

Mineralys Therapeutics, Inc.

$15.96 $1.04 B -4.26 51
LRMR

Larimar Therapeutics, Inc.

$1.87 $119.41 M -1.24 65
ELVN

Enliven Therapeutics, Inc.

$16.40 $803.76 M -8.53 62
VRDN

Viridian Therapeutics, Inc.

$13.57 $1.11 B -4.05 143
MRUS

Merus N.V.

$55.14 $3.82 B -13.27 260
STOK

Stoke Therapeutics, Inc.

$9.36 $510.48 M 11.4 128
CRNX

Crinetics Pharmaceuticals, Inc.

$29.76 $2.79 B -7.83 437
HOWL

Werewolf Therapeutics, Inc.

$1.15 $51.38 M -0.7 46
PTGX

Protagonist Therapeutics, Inc.

$45.66 $2.83 B 58.55 124
DSGN

Design Therapeutics, Inc.

$3.81 $217.42 M -3.87 56
GLUE

Monte Rosa Therapeutics, Inc.

$3.97 $244.19 M 33.08 142
ELYM

Eliem Therapeutics, Inc.

$5.11 $342.68 M -2.3 9
ANEB

Anebulo Pharmaceuticals, Inc.

$1.12 $45.81 M -4.46 2
OPT

Opthea Limited

$3.41 $4.20 B -1.52 33
DICE

DICE Therapeutics, Inc.

$47.55 $2.27 B -21.91 71